SightfileU.S. market data from official filings

VERICEL CORP COM (VCEL)

Name: VERICEL CORP COM (VCEL) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0000887359 · EDGAR filings · Updated 2026-06-30

VERICEL CORP COM (VCEL) has reported institutional ownership of 108.5%, with 279 institutional managers holding positions valued at $1.78B per the latest 13F reporting period.

Institutional ownership

108.5%

Institutional managers

279

Reported 13F value

$1.78B

Insider activity

103 trans.

−$7.71M net selling

Latest updates

2026-06-30 — Insider transaction reported (Form 4)
2026-06-30 — Insider transaction reported (Form 4)
2026-06-30 — Insider transaction reported (Form 4)
2026-06-30 — Insider transaction reported (Form 4)
2026-06-26 — Notice of proposed sale filed (Form 144)
2026-06-26 — Notice of proposed sale filed (Form 144)

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, VERICEL CORP COM has 279 institutional holders and institutional ownership of 108.5%.

Insider activity

Insiders reported 103 transactions (0 buys, 20 sells) across 13 reporting insiders, with a net reported value of −$7.71M.

Related companies

NURIX THERAPEUTICS INC (NRIX) · ADDUS HOMECARE CORP COM (ADUS) · ANI PHARMACEUTICALS INC (ANIP) · OCULAR THERAPEUTIX INC (OCUL) · PEDIATRIX MEDICAL GROUP INC (MD) · ZYMEWORKS INC (ZYME)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-30.